Phaarmasia Ltd

Phaarmasia Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Phaarmasia Ltd

₹ 120 5.00%
11 Feb - close price
phaarmasia.in BSE: 523620
About

Incorporated in 1981, Phaarmasia Ltd is engaged in manufacturing and marketing of Cosmetics, Oral Contraceptive Pills (OCP) and Combipack with Iron Tablets

Key Points

Business Overview:[1][2]
Company provides various therapeutic dosage combinations for Ministry of Health & Family Welfare and also for exports. In FY20, company became a Sick Industrial Company under SICA and was referred to BIFR.

Website BSE
  • Market Cap ₹ 81.9 Cr.
  • Current Price ₹ 120
  • High / Low ₹ 132 / 23.6
  • Stock P/E 35.8
  • Book Value ₹ 15.7
  • Dividend Yield 0.00 %
  • ROCE -16.5 %
  • ROE -16.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter
  • Debtor days have improved from 80.9 to 46.6 days.

Cons

  • Stock is trading at 7.63 times its book value
  • The company has delivered a poor sales growth of 4.10% over past five years.
  • Company has a low return on equity of -10.7% over last 3 years.
  • Earnings include an other income of Rs.19.8 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
8 8 7 9 5 10 8 6 5 5 7 17 16
9 8 7 9 6 10 8 7 6 6 7 15 15
Operating Profit -1 -0 -0 -0 -1 0 0 -1 -1 -1 0 2 1
OPM % -8% -3% -5% -3% -11% 3% 2% -13% -17% -11% 1% 10% 5%
0 0 0 0 0 0 0 0 0 0 0 0 19
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit before tax -1 -0 -0 -0 -1 0 0 -1 -1 -1 0 2 20
Tax % 0% -67% 0% -6% 4% -9% -12% 0% 1% 2% 12% -2% 18%
-1 -0 -0 -0 -1 0 0 -1 -1 -1 0 2 16
EPS in Rs -0.86 -0.13 -0.40 -0.23 -0.82 0.69 0.41 -0.94 -1.03 -0.78 0.40 2.55 23.83
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
15 12 14 14 19 24 20 16 17 27 31 24 45
14 11 13 14 18 23 19 16 19 29 31 26 43
Operating Profit 1 1 1 0 1 1 1 -0 -2 -2 -1 -2 2
OPM % 6% 8% 5% 1% 3% 3% 4% -0% -10% -6% -3% -8% 4%
0 0 0 1 1 1 1 1 0 1 1 1 20
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 1 0 0 0 0 0 0 0 0 0 0 0
Profit before tax 0 0 0 0 1 1 1 0 -2 -1 -1 -2 21
Tax % 18% 39% 83% 37% 16% 6% 45% 33% -1% -12% -6% -1%
0 0 0 0 1 1 1 0 -2 -1 -1 -2 18
EPS in Rs 0.51 0.21 0.06 0.23 0.83 1.14 0.79 0.45 -2.27 -1.85 -0.76 -2.33 26.00
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 7%
5 Years: 4%
3 Years: 13%
TTM: 55%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -1%
TTM: 488%
Stock Price CAGR
10 Years: 15%
5 Years: 32%
3 Years: 65%
1 Year: 184%
Return on Equity
10 Years: -2%
5 Years: -8%
3 Years: -11%
Last Year: -17%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 7 7 7 7 7 7 7 7 7 7 7 7 7
Reserves 1 6 5 5 5 6 7 7 5 4 3 2 4
0 0 0 0 0 0 0 0 0 0 0 0 0
6 6 7 8 10 20 20 8 9 17 21 13 34
Total Liabilities 13 19 19 20 22 33 34 22 21 28 31 22 44
11 16 14 14 14 14 13 13 13 13 12 12 12
CWIP 0 0 0 0 0 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
3 4 5 6 8 19 20 9 8 16 19 9 32
Total Assets 13 19 19 20 22 33 34 22 21 28 31 22 44

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0 0 0 -0 1 0 0 0 -0 1 0 0
-0 -0 -0 -0 -1 -0 0 0 0 -0 0 -0
0 0 0 -0 0 0 -0 -0 0 -0 -0 -0
Net Cash Flow -0 0 0 -0 0 0 -0 0 -0 0 -0 -0

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 48 48 78 91 73 179 226 96 69 100 96 47
Inventory Days 14 80 12 56 43 135 125 66 112 103 126 57
Days Payable 58 185 216 293 249 403 374 166 214 269 298 224
Cash Conversion Cycle 4 -56 -127 -146 -133 -89 -24 -4 -33 -65 -76 -120
Working Capital Days -72 -79 -64 -43 -34 -13 7 8 -17 -39 -43 -71
ROCE % 6% 3% 2% 2% 6% 7% 8% 4% -12% -12% -5% -16%

Shareholding Pattern

Numbers in percentages

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51% 73.51%
0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05% 0.05%
26.42% 26.43% 26.43% 26.43% 26.43% 26.43% 26.43% 26.43% 26.43% 26.42% 26.44% 26.44%
No. of Shareholders 20,82220,77920,72220,68820,68220,64220,59620,61220,62020,51220,49720,404

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports